Back to results
US 11,725,020 B2Granted
Prodrugs of a CDK inhibitor for treating cancers
AssigneesRisen (Suzhou) Pharma Tech Co., Ltd., SHANGHAI JUNSHl BIOSCIENCES CO., LTD.
InventorsJiasheng Lu, Jiamin Gu, Gang Chen, Xiaolin Zhang, Feng Zhou, Xianqi Kong
Life of this patent
Estimating the term…
Abstract
There are provided compounds of Formula I, and pharmaceutically acceptable salts and esters thereof, and pharmaceutical compositions thereof, used for inhibition or modulation of the activity of cyclin dependent kinases (CDK) and/or glycogen synthase kinase-3 (GSK-3), for the treatment of disease states or conditions mediated by cyclin dependent kinases and/or glycogen synthase kinase-3, including cancers.
Claims20
A compound which is:
- or a pharmaceutically acceptable salt or ester thereof.
Dependencies are inferred from the claim text.